Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome
Posted: 03/27/2024 | By: Sarah Campen, PharmD

Santhosh et al reported results of a single-site phase III randomized double-blind trial which assessed the efficacy of topical diclofenac in the prevention of capecitabine-induced hand-foot syndrome in the Journal of Clinical Oncology..

Question 1 of 5

Which statement about hand-foot syndrome is FALSE?

Choose 1